Sort
16,300 grants matching “fatty liver disease”
Environmental chemical exposures during pregnancy and women's cardio-metabolic health
$413,810Dana Dabelea · University Of Colorado Denver · R01 · FY2024 · ES
Mechanism of Insulin Resistance in the Aged.
$413,750Kitt F Petersen · Yale University · R56 · FY2009 · AG
The genetics and pathophysiology of impaired Wnt signaling in metabolic syndrome
$413,750Arya Mani · Yale University · R01 · FY2011 · HL
Investigation of genetic and physiological causes of inherited Vascular and Metab
$413,750Arya Mani · Yale University · R01 · FY2010 · HL
Investigation of genetic and physiological causes of inherited Vascular and Metab
$413,750Arya Mani · Yale University · R01 · FY2009 · HL
The genetics and pathophysiology of impaired Wnt signaling in metabolic syndrome
$413,750Arya Mani · Yale University · R01 · FY2010 · HL
O-GlcNAc Modification in Metabolic Homeostasis
$413,750Xiaoyong Yang · Yale University · R01 · FY2010 · DK
Investigation of genetic and physiological causes of inherited Vascular and Metab
$413,750Arya Mani · Yale University · R01 · FY2011 · HL
The genetics and pathophysiology of impaired Wnt signaling in metabolic syndrome
$413,750Arya Mani · Yale University · R01 · FY2009 · HL
Novel Liver Signaling Pathways Controlling Adiposity
$413,714Terry D Hinds · University Of Kentucky · R01 · FY2023 · DK
Glycopathology of HCC: identification of the source cells of serum fucosylation
$413,676Anand S Mehta · Medical University Of South Carolina · U01 · FY2021 · CA
miR-378/378* promotes hepatic lipid accumulation and progression of NAFLD to NASH
$413,641Guisheng Song · University Of Minnesota · R01 · FY2015 · DK
miR-378/378* promotes hepatic lipid accumulation and progression of NAFLD to NASH
$413,641Guisheng Song · University Of Minnesota · R01 · FY2017 · DK
miR-378/378* promotes hepatic lipid accumulation and progression of NAFLD to NASH
$413,641Guisheng Song · University Of Minnesota · R01 · FY2018 · DK
miR-378/378* promotes hepatic lipid accumulation and progression of NAFLD to NASH
$413,641Guisheng Song · University Of Minnesota · R01 · FY2016 · DK
PGC-1 and the Control of Hepatic Gluconeogenesis
$413,478Bruce M Spiegelman · Dana-Farber Cancer Inst · R01 · FY2009 · DK
ANALYSIS OF INTRAHEPATIC MACROPHAGE PROFILES FOR PREDICTING RISK OF FIBROSIS DEVELOPMENT IN PATIENTS WITH DIFFERENT TYPES OF CHRONIC LIVER DISEASE
$413,478Heather L Stevenson · University Of Texas Med Br Galveston · R01 · FY2024 · DK
Transplantation of Endothelial Cells
$413,437Sanjeev Gupta · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · DK
Mechanisms of Regulation of Retinoic Acid Homeostasis
$413,423Nina Isoherranen · University Of Washington · R01 · FY2018 · GM
Role of Soluble Epoxide Hydrolase in Alcohol-Associated Liver Disease
$413,410Irina A. Kirpich · University Of Louisville · R01 · FY2024 · AA
Mechanism and application of sugar-induced phage production by the probiotic gut symbiont Lactobacillus reuteri
$413,378Jan-Peter Van Pijkeren · University Of Wisconsin-Madison · R01 · FY2022 · AT
Project 4: Interrogating and harnessing age-related IFN signaling and innate immunity in HCC prevention and therapy
$413,341Gen-Sheng Feng · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2022 · AG
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells
$413,297Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells
$413,297Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
A novel cholinergic circuitry in alcoholic liver disease (NIAAA)
$413,297Jun Wu · University Of Michigan At Ann Arbor · R01 · FY2024 · AA